Urinary proteomics to support diagnosis of stroke

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Dawson, Jesse ^a   Walters, Matthew ^a   Delles, Christian ^a   Mischak, Harald ^a,b   Mullen, William ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b Mosaiques Diagnostics   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSINOGEN; ANTIHYPERTENSIVE AGENT; BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER; CALCIUM CHANNEL BLOCKING AGENT; CERULOPLASMIN; COLLAGEN; COLLAGEN ALPHA 1 CHAIN; COLLAGEN ALPHA 1 CHAIN ISOFORM 1; COLLAGEN ALPHA 2 CHAIN; COLLAGEN ALPHA 3 CHAIN; FIBRINOGEN; FIBRINOGEN A ALPHA CHAIN; FIBRINOGEN ALPHA CHAIN ISOFORM 1; FRAS1 RELATED EXTRACELLULAR MATRIX PROTEIN 3; FXYD DOMAIN CONTAINING ION TRANSPORT REGULATOR 4; HEMOGLOBIN A; IMMUNOGLOBULIN RECEPTOR; INTER ALPHA TRYPSIN INHIBITOR; INTER ALPHA TRYPSIN INHIBITOR HEAVY CHAIN H4; MEMBRANE PROTEIN; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN PHOSPHATASE 1 REGULATORY SUBUNIT 3F ISOFORM 1; TAMM HORSFALL GLYCOPROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; CAPILLARY ELECTROPHORESIS; CASE CONTROL STUDY; CEREBROVASCULAR DISEASE; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HYPERTENSION; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MICRO TIME OF FLIGHT MASS SPECTROMETRY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; ONLINE ANALYSIS; PEPTIDE ANALYSIS; PROTEOMICS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STROKE; STROKE PATIENT; SUPPORT VECTOR MACHINE; SYMPTOM; TANDEM MASS SPECTROMETRY; TRANSIENT ISCHEMIC ATTACK; URINALYSIS; CHEMISTRY; MIDDLE AGED; PROTEINURIA; URINE;

AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; BIOLOGICAL MARKERS; CHROMATOGRAPHY, LIQUID; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; PROTEINURIA; PROTEOMICS; STROKE;

EID: 84861216159     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035879     Document Type: Article

References (33)

1. Libman RB, Wirkowski E, Alvir J, Rao TH, (1995) Conditions that mimic stroke in the emergency department. Implications for acute stroke trials. Arch. Neurol. 52: 1119-1122.
2. Dawson J, Lamb E, Quinn TJ, Horvers M, Verrijth MJ, et al. (2009) A Recognition Tool for Transient Ischaemic Attack. Quarterly Journal of Medicine 102: 43-49.
3. Harbison J, Hossain O, Jenkinson D, Nor AM, Davis J, et al. (2003) Diagnostic accuracy of stroke referrals from primary care, emergency room physicians, and ambulance staff using the Face Arm Speech Test. Stroke 34: 71-76.
4. Nor AM, Davis J, Sen B, Shipsey D, Louw SJ, et al. (2005) The recognition of stroke in the emergency room (ROSIER) scale: development and validation of a stroke recognition instrument. 5. Lancet Neurol 4: 727-34.
5. Chalela JA, Kidwell CS, Nentwich LM, Luby M, Butman JA, et al. (2007) Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet 27: 293-98.
6. Doubal FN, Dennis MS, Wardlaw JM, (2011) Characteristics of patients with minor ischaemic strokes and negative MRI: a cross sectional study. Journal of Neurology Neurosurgery and Psychiatry 82: 540-42.
7. Sylaja PN, Coutts SB, Krol A, Hill MD, Demchuk AM, (2008) When to expect negative diffusion-weighted images in stroke and transient ischemic attack. Stroke 39: 1898-90.
8. Dayon L, Turck N, Berrocoso TG, Walter N, Burkhard PR, et al. (2011) Brain extracellular fluid protein changes in acute stroke patients. Journal of Proteome Research 10: 1043-51.
9. Ning MM, Sarracino D, Buonanno F, Krastins B, Chou S, et al. (2010) Proteomic protease substrate profiling of tPA treatment in acute ischemic stroke patients. Trans Stroke Res 1: 268-75.
10. Delles C, Schiffer E, von zur Muhlen C, Peter K, Rossing P, et al. (2010) Urinary proteomic diagnosis of coronary artery disease: identification and clinical validation in 623 individuals. Journal of Hypertension 28: 2316-22.
11. Snell-Bergeon JK, Maahs DM, Ogden LG, Kinney GL, Hokanson JE, et al. (2009) Evaluation of urinary biomarkers for coronary artery disease, diabetes, and diabetic kidney disease. Diabetes Technol Ther. 11: 1-9.
12. Carty DM, Siwy J, Brennand JE, Zurbig P, Mullen W, et al. (2011) Urinary proteomics for prediction of preeclampsia. Hypertension 57: 561-9.
13. Benjamini Y, Hochberg Y, (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc B (Methodological) 57: 125-133.
14. Mischak H, Coon JJ, Novak J, Weissinger EM, Schanstra JP, et al. (2009) Capillary electrophoresis-mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: An update of recent developments. Mass Spectrom Rev 28: 703-24.
15. Kashyap RS, Nayak AR, Deshpande PS, Kabra D, Purohit HJ, et al. (2009) Inter-alpha-trypsin inhibitor heavy chain 4 is a novel marker of acute ischemic stroke. Clin Chim Acta. 402; 160-3.
16. Feschenko MS, Donnet C, Wetzel RK, Asinovski NK, Jones LR, et al. (2003) Phospholemman, a single-span membrane protein, is an accessory protein of Na, K-ATPase in cerebellum and choroid plexus. J Neurosci 23: 2161-2169.
17. Gimelreich D, Popovtzer MM, Wald H, Pizov G, Berlatzky Y, et al. (2001) Regulation of ROMK and channel-inducing factor (CHIF) in acute renal failure due to ischemic reperfusion injury. Kidney International 59: 1812-1820.
18. Ikonen E, Parton RG, Hunziker W, Simons K, Dotti CG, (1993) Transcytosis of the polymeric immunoglobulin receptor in cultured hippocampal neurons. Current Biology 10: 635-44.
19. Gong CX, Singh TJ, Grundke-Iqbal I, Iqbal K, (1993) Phosphoprotein phosphatase activities in Alzheimer disease brain. Journal of Neurochemistry 61: 921-27.
20. Yu C, Kastin AJ, Pan W, (2007) Gamma glutamyl transpeptidase is a dynamic indicator of endothelial response to stroke. Experimental Neurology 203: 116-22.
21. Walther T, Olah L, Harms C, Maul B, Bader M, et al. (2002) Ischemic injury in experimental stroke depends on angiotensin II. FASEB J 16: 169-176.
22. Turner JJ, Stacey JM, Harding B, Kotanko P, Lhotta K, et al. (2003) Uromodulin mutations cause familial juvenile hyperuricemic nephropathy. J Clin Endocrinol Metab. 88: 1398-401.
23. Su SJ, Chang KL, Lin TM, Huang YH, Yeh TR, (1997) Uromodulin and Tamm-Horsfall protein induce human monocytes to secrete TNF and express tissue factor. Journal of Immunology 158: 3449-3546.
24. Mischak H, Allmaier G, Apweiler R, Attwood T, Baumann M, et al. (2010) Recommendations for biomarker identification and qualification in clinical proteomics. Sci. Transl. Med. 2: 46ps42.
25. Dawson J, Quinn TJ, Rafferty M, Higgins P, Ray G, et al. (2011) Aspirin Resistance and Compliance with Therapy. Cardiovascular Therapeutics 29: 301-07.
26. Good DM, Zürbig P, Argiles A, Bauer HW, Behrens G, et al. (2010) Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Mol. Cell Proteomics 9: 2424-2437.
27. Haubitz M, Fliser D, Rupprecht H, Floege J, Haller H, et al. (2005) Defining renal diseases based on proteome analysis. Nephrology Dialysis Transplantation 20: V20.
28. Wittke S, Fliser D, Haubitz M, Bartel S, Krebs R, et al. (2003) Determination of peptides and proteins in human urine with capillary electrophoresis-mass spectrometry, a suitable tool for the establishment of new diagnostic markers. J Chromatogr. 1013: 173-181.
29. Theodorescu D, Wittke S, Ross MM, Walden M, Conway M, et al. (2006) Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis. Lancet Oncol 7: 230-240.
30. Siwy J, Schiffer E, Brand K, Schumann G, Rossing K, et al. (2009) Quantitative Urinary Proteome Analysis for Biomarker Evaluation in Chronic Kidney Disease. J. Proteome. Res. 8: 268-281.
31. Siwy J, Mullen W, Golovko I, FrankeJ, Zuerbig P, (2011) Human urinary peptide database for multiple disease biomarker discovery. Proteomics Clin Appl. 5: 367-374.
32. Zürbig P, Renfrow MB, Schiffer E, Novak J, Walden M, et al. (2006) Biomarker discovery by CE-MS enables sequence analysis via MS/MS with platform-independent separation. Electrophoresis 27: 2111-2125.
33. Dakna M, Harris K, Kalousis A, Carpentier S, Kolch W, et al. (2011) Addressing the challenge of defining valid proteomic biomarkers and classifiers. BMC. Bioinformatics 11: 594.